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Book Note
BIOBAZAAR: THE OPEN SOURCE REVOLUTION AND
BIO-TECHNOLOGY, by Janet Hope 1
JUSTIN LIM
IN THIS ORIGINAL AND THOUGHT-PROVOKING BOOK, Janet Hope discusses how
open-source principles could be placed within a new context-biotechnology.
Using empirical research, interviews with key stakeholders, and, especially, case
studies, Hope analyzes the success of the open-source movement from both
inside and outside the software industry, before ultimately applying it to
medical (red) and agricultural (green) biotechnology. Rather than making any
definitive conclusions, the book is meant to serve as an important contribution
to the literature on intellectual property and biotechnology by providing an ana-
lytical framework on which open-source biotechnology, or a biobazaar, could be
implemented.
In the introductory chapter, the author draws an analogy between software
and biotechnology in the context of the open-source movement. Like a bazaar,
open-source biotechnology exists where decision-making is autonomous, the
parties control themselves and their resources, and participation is entirely vol-
untary. Chapter two provides the background by explaining the proliferation of
intelletual property rights (especially patents), and how it may lead to what the
author refers to as the tragedy of the anti-commons-a situation where a resource
is under-utilized due to excessively fragmented intellectual property rights, lead-
ing to higher transaction costs as researchers enter a veritable patent minefield.
Chapter three explains the theoretical basis and underlying assumptions for these
intellectual property rights, before dismissing their applicability to biotechnol-
ogy, which largely consists of uncodified information. The author argues instead
that the true purpose of intellectual property rights in biotechnology is to pro-
tect monopolies within the knowledge game, where key players strategically ac-
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quire as many patents as possible, while employing various blocking strategies
to neutralize the value of competitors' intellectual property.
To address the failure of traditional proprietary biotechnology, chapter four
proposes a bazaar-like governance structure with incentives and control mecha-
nisms centered on promoting the widespread distribution and sharing of the
object of production to anyone who wishes to participate in its development.
Not only does this reduce transaction costs, but it also enhances the use value of
an invention, increasing the likelihood that it will be improved in the future.
Chapter five articulates the underlying characteristics of open-source licensing
(independent of the software industry) as a way of exploiting technology through
non-proprietary mechanisms. The author distills these into a set of general
principles that could be used to guide open-source biotechnology: the credible
commitment of participants, competition, reciprocity/disclosure, and a com-
plier-centered approach. After comparing case studies in both the software and
biotechnology industries, Hope concludes that none of the differences pose an
insurmountable obstacle to implementing open-source biotechnology.
With the theoretical foundation of the biobazaar set, Hope analyzes the
feasibility of applying open-source principles in the context of biotechnology,
with reference to three key principles: technology development, licensing, and
commercial exploitation. The next two chapters deal with these three principles,
adapting them to provide the framework for the biobazaar. First, biotechnology
is sufficiently modular (it is divisible into components that can be independently
produced), granular (it can accommodate various types and levels of contribu-
tion), and integrated to be developed through an open-source approach. As is
the case with the software industry, the development of biotechnology would
rely primarily on the internet as a tool for coordinating every stage of knowledge
production. Second, open-source licenses, especially those complying with a
voluntary standard, would provide a mechanism for establishing and maintain-
ing connections among open-source participants. Lastly, open-source provides a
mechanism for incorporating contributions from both non-commercial and
commercial sources on a non-proprietary basis, whether through an increase in
process value or use value. The final chapter attempts to counter the prevailing
proprietary culture of key participants in the biotechnology industry. After ana-
lyzing a number of fledgling open-source biobazaar initiatives, Hope concludes
that a small number of stakeholders can act as a catalyst for shifting biotechnol-
ogy away from operating solely on the basis of proprietary exclusivity.
